Publications by authors named "Jean Marc Tourani"

Claim this Profile
A
Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).
Séverine Racadot, Isabelle Thennevet, Yaelle Ouldbey, Marie-Christine Kaminsky, Mathieu Bosset, Jean-Marc Tourani

Eur J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Non-programmed hospitalization of elderly patients with cancer: Which care pathway?].
Simon Valero, Guillaume Simet, Thomas Fauchier, Amélie Jamet, Patrick Bouchaert, Jean-Marc Tourani

Bull Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of cancer and management in elderly nursing home residents. A descriptive study in 45 French nursing homes.
Evelyne Liuu, Nicolas Guyot, Simon Valero, Amelie Jamet, Houria El Ouazzani, Jean-Marc Tourani

Eur J Cancer Care (Engl)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
Lionnel Geoffrois, Laurent Martin, Dominique De Raucourt, Xu Shan Sun, Yungan Tao, Jean-Marc Tourani

J Clin Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.
Guy Meyer, Benjamin Besse, Hélène Doubre, Anaïs Charles-Nelson, Sandro Aquilanti, Jean-Marc Tourani

Eur Respir J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
Yungan Tao, Anne Auperin, Christian Sire, Laurent Martin, Cedric Khoury, Jean-Marc Tourani

J Clin Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supportive Care Organization in France: a national in-depth survey among patients and oncologists.
Florian Scotté, Christian Hervé, Pauline Leroy, Jean-Marc Tourani, René-Jean Bensadoun

Support Care Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions.
Claire Villalva, Ulrich Cortes, Michel Wager, Jean-Marc Tourani, Pierre Rivet

Int J Mol Sci· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study.
Nicolas Isambert, Jean Pierre Delord, Jean Marc Tourani, Pierre Fumoleau, Alain Ravaud

Br J Clin Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.
David Tougeron, Ulrich Cortes, Aurélie Ferru, Claire Villalva, Christine Silvain, Jean Marc Tourani

Cancer Chemother Pharmacol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.
Françoise Mornex, Karine Peignaux, Thierry Germain, Virginie Wautot, Nadia Chouaki, Jean-Marc Tourani

Lung Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
Jean Louis Lefebvre, Yoann Pointreau, Frederic Rolland, Marc Alfonsi, Alain Baudoux, Jean Marc Tourani

J Clin Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of IV vinflunine in combination with carboplatin in chemonaive patients with advanced non-small cell lung cancer.
Caroline Tournoux-Facon, Gilles Robinet, Marie-Claire Pinel, Pierre Ferre, Jean-Marc Tourani

Am J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two French tertiary centres.
David Tougeron, Bernard Roullet, Bernard Paillot, Hadji Hamidou, Jean-Marc Tourani

Dig Liver Dis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patients.
Caroline Tournoux-Facon, Hélène Senellart, Etienne Lemarie, Jean Marc Tourani, Stéphanie Favrel

J Thorac Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
Claire Villalva, Severine Martin-Lannerée, Ulrich Cortes, Fatima Dkhissi, Michel Wager, Jean-Marc Tourani

Int J Cancer· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial.
Ewa Wierzbicka-Hainaut, Bruno Sassolas, Laurent Mourey, Bernard Guillot, Christophe Bedane, Jean Marc Tourani

Melanoma Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors.
Anne-Claire Barbot, Pascale Mussault, Pierre Ingrand, Jean-Marc Tourani

J Clin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
Florian Scotté, Eugeniu Banu, Jacques Medioni, Eric Levy, Christelle Ebenezer, Jean Marc Tourani

Cancer· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary results of the Prostacox phase II trial in hormonal refractory prostate cancer.
Baptiste Albouy, Jean-Marc Tourani, Patrick Allain, Frederic Rolland, Frederic Staerman

BJU Int· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.
Jean-Luc Labourey, Didier Cupissol, Gilles Calais, Jean-Marc Tourani, Fréderic Kohser

Am J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study.
David Planchard, Hugues Bourgeois, Michèle Adoun, Jean-François Paitel, Pierre Blanc, Jean-Marc Tourani

Am J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of pegylated liposomal doxorubicin in combination with ifosfamide in pretreated ovarian cancer patients.
Hugues Bourgeois, Florence Joly, Eric Pujade-Lauraine, Hervé Cure, Jean Paul Guastalla, Jean-Marc Tourani

Am J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I-II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer.
Hugues Bourgeois, Aurélie Ferru, Alain Lortholary, Thierry Delozier, Michèle Boisdron-Celle, Jean-Marc Tourani

Am J Clin Oncol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.
Florian Scotté, Jean-Marc Tourani, Eugeniu Banu, Michel Peyromaure, Eric Levy

J Clin Oncol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis